KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
The cognitively operated system is a mother patent invention, first launched in India
Mindset disagrees with and denies the allegations set forth from Reunion.
36.4% of patients with diabetic neuropathic pain in 2021 were completely treatment refractory and would benefit from new treatment options.
The global VR market to grow at a compound annual growth rate of 13% from $7 billion in 2018 to $28 billion in 2030.
This dense phase often resembles liquid droplets exhibiting higher protein density and weaker molecular motion than the surrounding medium.
Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's
The treatment of chorea associated with HD is within the scope of this Orphan Drug Designation
During her tenure at the University of South Florida Dr. Hunter was responsible for managing the patent portfolio associated with Alzamend’s two product candidates, AL001 and AL002
AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectrum of the disease, commitment to patients with advanced Parkinson's disease, and new studies in spasticity and cervical dystonia
Subscribe To Our Newsletter & Stay Updated
